“How to manage challenging behaviors in children with autism is a question that many parents have,” said CARD director of clinical quality, Sienna Greener-Wooten, PhD, BCBA. “We are eager to give families advice on the subject."
SAN DIEGO (PRWEB) July 28, 2015
Center for Autism and Related Disorders (CARD) today announced that it will partner with Autism Research Group (ARG), Autism Care and Treatment Today! (ACT Today!) and Lineagen Delayed Development Testing Clinic to host an event that will offer families access to critical autism resources. The event is open to all families and will run from 9:00 a.m. to 5:00 p.m. on Saturday, Aug. 1, 2015 at the San Diego Marriott Del Mar’s Rancho Santa Fe Ballroom, located at 11966 El Camino Real, San Diego, Calif. 92130. Presentations will cover topics, such as: autism treatment options; how to handle challenging behaviors; how to apply for a financial grant; and information on genetic testing for individuals with autism. Genetic testing for children will be available on site using a painless cheek swab. The results will help pinpoint genetic causes for delayed development, including autism spectrum disorder (ASD). Registration is mandatory and child-friendly activities will be provided.
“How to manage challenging behaviors in children with autism is a question that many parents have,” said CARD director of clinical quality, Sienna Greener-Wooten, PhD, BCBA. “We are eager to give families advice on the subject and excited to offer families access to all these wonderful resources in one place.”
In addition to the presentation by CARD on applied behavior analysis (ABA) therapy and addressing challenging behaviors, ACT Today! will talk to families about grant opportunities and discuss the application process. Lineagen Delayed Development Testing Clinic will present on understanding the role of genetics in a disorder such as ASD and will administer the testing.
The genetic test, Lineagen FirstStepDx Plus chromosomal microarray (CMA), has more extensive genetic content and provides a higher performance with twice the detection rate for genetic variations associated with ASD as compared to other available tests. Genetic testing can help families understand the “recurrence risk,” or the potential that this condition could occur again to another child in the family.
To register for the morning testing group between 9:00 a.m. and noon, visit http://tinyurl.com/nnozmd6. To register for the afternoon testing group between 1:00 and 5:00 p.m., visit http://tinyurl.com/nca62a2. During registration, parents will be asked if they want their child to be swabbed and then an appointment will be made. At the swab appointments, children will be evaluated by a doctor and then cheek swabbed, with test results provided in about four to six weeks.
Genetic testing for delayed development is usually covered by insurance, however any out-of-pocket cost for the test is guaranteed in writing before the test is done. Parents should bring their insurance card and have the most recent medical records for their child, particularly any diagnosis for delayed development, ASD or intellectual disability. Parents that have their children tested will have access to genetic counseling before and after the test and a detailed, but easy-to-read report on the results of the test.
About Center for Autism and Related Disorders (CARD)
CARD treats individuals of all ages who are diagnosed with autism spectrum disorder (ASD) at treatment centers around the globe. CARD was founded in 1990 by leading autism expert and clinical psychologist Doreen Granpeesheh, PhD, BCBA-D. CARD treats individuals with ASD using the principles of applied behavior analysis (ABA), which is empirically proven to be the most effective method for treating individuals with ASD and recommended by the American Academy of Pediatrics and the US Surgeon General. CARD employs a dedicated team of nearly 2,000 individuals across the nation and internationally. For more information, visit http://www.centerforautism.com or call (855) 345-2273.
Based in Salt Lake City, Utah, Lineagen's mission is to accelerate and enhance the diagnostic evaluation of medical conditions so that the best possible outcomes can be achieved for patients and their families. Our first commercial offering, FirstStepDx PLUS, provides physicians with a fully integrated genetic testing, counseling and developmental screening service to aid in the diagnostic evaluation of individuals with autism spectrum disorder (ASD) or other disorders of childhood development. In addition to our deep commitment to ASD and developmental delay, we have ongoing scientific programs in the areas of multiple sclerosis (MS) and chronic obstructive pulmonary disease (COPD). For additional information, please visit http://www.lineagen.com.
About Autism Care and Treatment Today! (ACT Today!)
ACT Today! is a 501(c)3 non-profit organization dedicated to providing resources and funding to families of children with autism who cannot afford or access the necessary tools their children need to reach their full potential. For more information about ACT Today!, visit http://www.act-today.org.
About ACT Today! for Military Families
ACT Today! for Military Families (ATMF) is a national program of ACT Today!. ATMF works to improve awareness and delivery of effective autism services, and provides financial assistance to military families to help defray out-of-pocket costs associated with autism treatments, services and other quality of life programs. For more information about ATMF, visit http://www.acttodayformilitaryfamilies.org.
About Autism Research Group (ARG)
ARG is dedicated to identifying, evaluating and disseminating treatments that make a real, measurable difference in the lives of individuals with autism spectrum disorder (ASD) and their families. Founded in 2011 by a core group of autism research scientists who are dedicated to cultivating an autism-friendly world through cutting-edge treatment research, ARG uses science to improve the quality of life for people with ASD and the families who love them. The mission of ARG is to create a world that meets the treatment needs of individuals with ASD and their families through scientific research that is judiciously initiated, rigorously evaluated and effectively disseminated. For more information about ARG, visit http://www.autismresearchgroup.org.